Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-11-21
DOI
10.3389/fphys.2014.00455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Executive Summary: Heart Disease and Stroke Statistics—2014 Update
- (2014) Alan S. Go et al. CIRCULATION
- High-Density Lipoprotein
- (2014) Thomas F. Lüscher et al. CIRCULATION RESEARCH
- Mendelian randomization of blood lipids for coronary heart disease
- (2014) Michael V. Holmes et al. EUROPEAN HEART JOURNAL
- Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
- (2014) S. Kuhnast et al. EUROPEAN HEART JOURNAL
- Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study
- (2014) Roberta Ramonda et al. JOINT BONE SPINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular effects of statins, beyond lipid-lowering properties
- (2014) Christos G. Mihos et al. PHARMACOLOGICAL RESEARCH
- Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-α Treatment
- (2014) Kuo-Wei Yeh et al. PLoS One
- Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients
- (2014) Gaia Sirimarco et al. STROKE
- Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification
- (2014) Grigorios Korosoglou et al. Frontiers in Physiology
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis
- (2013) Brendan M. Everett et al. AMERICAN HEART JOURNAL
- Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies
- (2013) M. Ferwana et al. DIABETIC MEDICINE
- Long-chain metabolites of α-tocopherol occur in human serum and inhibit macrophage foam cell formation in vitro
- (2013) Maria Wallert et al. FREE RADICAL BIOLOGY AND MEDICINE
- High-density lipoproteins: A consensus statement from the National Lipid Association
- (2013) Peter P. Toth et al. Journal of Clinical Lipidology
- High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
- (2013) Dominic De Nardo et al. NATURE IMMUNOLOGY
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Tumor Necrosis Factor α Inhibitor Use and Decreased Risk for Incident Coronary Events in Rheumatoid Arthritis
- (2013) Androniki Bili et al. ARTHRITIS CARE & RESEARCH
- Use of Niacin in the United States and Canada
- (2013) Cynthia A. Jackevicius et al. JAMA Internal Medicine
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- High-Density Lipoproteins Inhibit Vascular Endothelial Inflammation by Increasing 3β-Hydroxysteroid-Δ24 Reductase Expression and Inducing Heme Oxygenase-1
- (2012) Ben J. Wu et al. CIRCULATION RESEARCH
- Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme
- (2012) U. Landmesser et al. EUROPEAN HEART JOURNAL
- Almanac 2012: interventional cardiology: The national society journals present selected research that has driven recent advances in clinical cardiology
- (2012) Pascal Meier et al. HEART
- Infliximab is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritis -- A Randomized Trial
- (2012) L.-S. TAM et al. JOURNAL OF RHEUMATOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
- (2011) Renata Micha et al. AMERICAN JOURNAL OF CARDIOLOGY
- Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
- (2011) Uchechukwu K. Sampson et al. Current Atherosclerosis Reports
- Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
- (2011) Christian Besler et al. JOURNAL OF CLINICAL INVESTIGATION
- Progress and challenges in translating the biology of atherosclerosis
- (2011) Peter Libby et al. NATURE
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
- (2010) Harvey White et al. AMERICAN HEART JOURNAL
- Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability
- (2010) Christian Erbel et al. BASIC RESEARCH IN CARDIOLOGY
- Heart Disease and Stroke Statistics—2011 Update
- (2010) Véronique L. Roger et al. CIRCULATION
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Canakinumab
- (2010) Eugen Dhimolea mAbs
- Monocytes in atherosclerosis: subsets and functions
- (2010) Kevin J. Woollard et al. Nature Reviews Cardiology
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
- Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice
- (2009) Jitske de Vries-van der Weij et al. ATHEROSCLEROSIS
- Chemokines in the vascular inflammatory response of atherosclerosis
- (2009) A. Zernecke et al. CARDIOVASCULAR RESEARCH
- Oxidative Stress, Endothelial Dysfunction and Atherosclerosis
- (2009) Victor Victor et al. CURRENT PHARMACEUTICAL DESIGN
- Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects
- (2009) Kendrea M Muldrew et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
- (2009) C. Erbel et al. JOURNAL OF IMMUNOLOGY
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Phospholipase A2 inhibitors in atherosclerosis: the race is on
- (2009) Marshall A Corson LANCET
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Loss of SR-A and CD36 Activity Reduces Atherosclerotic Lesion Complexity Without Abrogating Foam Cell Formation in Hyperlipidemic Mice
- (2008) Jennifer J. Manning-Tobin et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Tumor necrosis factor-α inhibition protects against endotoxin-induced endothelial glycocalyx perturbation
- (2008) M. Nieuwdorp et al. ATHEROSCLEROSIS
- Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
- (2008) Patrick W. Serruys et al. CIRCULATION
- The LDL modification hypothesis of atherogenesis: an update
- (2008) Daniel Steinberg JOURNAL OF LIPID RESEARCH
- The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent
- (2008) Emile R. Mohler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial
- (2008) Jean-Claude Tardif et al. LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started